LY2090314
LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM; may improve the efficacy of platinum-based chemotherapy regimens. Phase 2.
Product Specifications
CAS Number
603288-22-8
Product Name Alternative
LY2090314 | LY-2090314 | LY 2090314.
Purity
>98% (HPLC)
Solubility
Ethanol: 2 mg/mL warmed (3.9 mM) ; DMSO: 100 mg/mL (195.11 mM)
Smiles
O=C (C (C1=CN2C3=C1C=C (F) C=C3CN (C (N4CCCCC4) =O) CC2) =C5C6=CN=C7C=CC=CN76) NC5=O
Molecular Formula
C28H25FN6O3
Molecular Weight
512.53
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
3- (9-fluoro-2- (piperidine-1-carbonyl) -1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl) -4- (imidazo[1,2-a]pyridin-3-yl) -1H-pyrrole-2,5-dione
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog